Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · Q4 FY26

Procter & Gamble Health Q4 FY26 Results: Net Profit ₹94.6 Cr, Up 54.6% YoY

Procter & Gamble Health Ltd reported revenue from operations of ₹370.4 Cr (+19.1% YoY) and net profit of ₹94.6 Cr (+54.6% YoY) for Q4 FY26.

Q4 FY26 at a glance · ₹ crore
MetricQ4 FY26Q3 FY26Q4 FY25
Revenue from operations370.4373.9311.0
Other income4.04.43.1
Total income374.4378.2314.1
Profit before exceptional items & tax133.2108.878.5
Profit before tax133.2108.878.5
Net profit94.677.661.2
Operating margin35.6%28.8%25.0%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Growth
Net profit, year on year+54.60%
Net profit, quarter on quarter+21.90%
Revenue, year on year+19.10%
Source

BSE results filing, NSE: PGHL. Figures extracted from the filing.

Read the filing ↗

Procter & Gamble Health Ltd: key numbers

Share price
₹5,406.00
Market cap
₹8,974 Cr
Revenue (annual)
₹1,408 Cr
Net profit (annual)
₹326.9 Cr
P/E (TTM)
25.1×Sector 50.4×
Promoter holding
51.82%+0.00% QoQ
FII holding
6.33%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Procter & Gamble Health Ltd

All →
19:33 IST NSE
Other Announcement

Procter & Gamble Health Other Announcement

Procter & Gamble Health informed shareholders about an extended SEBI-mandated special window for re-lodging rejected physical share transfer requests until February 4, 2027.

17:19 IST BSE
Management Change

Procter & Gamble Health Management Change

Procter & Gamble Health shareholders approved the re-appointment of Mr. S. Madhavan as an Independent Director for a five-year term starting November 15, 2026.

Execution
5 years
17:46 IST BSE
Annual General Meeting

Procter & Gamble Health Annual General Meeting

Procter & Gamble Health held its 59th Annual General Meeting on September 3, 2026, where shareholders discussed financial results and directorial appointments.